Sustained nicorandil administration reduces the infarct size in ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention

OBJECTIVE: Currently, there is still no effective strategy to diminish the infarct size (IS) in patients with ST-segment elevation myocardial infarction (STEMI). According to a previous animal study, nicorandil treatment is a promising pharmaceutical treatment to limit the infarct area. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shanjie, Duan, Yu, Feng, Xinyu, Liu, Liang, Shi, Zhaofeng, Wang, Bo, Xia, Chenhai, Man, Wanrong, Wang, Haichang, Zhao, Zhijing, Sun, Dongdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457402/
https://www.ncbi.nlm.nih.gov/pubmed/30821716
http://dx.doi.org/10.14744/AnatolJCardiol.2018.57383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457402/
https://www.ncbi.nlm.nih.gov/pubmed/30821716
http://dx.doi.org/10.14744/AnatolJCardiol.2018.57383

Ejemplares similares